Company: GHRS
Filing Date: 2025-07-29
Form Type: 20-F/A
Source: 0001140361-25-027850
Chunk: 117

Company: GH Research PLC
Filing Date: 2025-07-29
Form: 20-F/A
Chunk 117
---
 product candidates incorporating the relevant intellectual property. 61 Table of Contents Disputes may arise regarding intellectual property subject to a license or collaboration agreement, including the following:

| • | the scope of rights granted under the agreement and other interpretation-related issues; |

| • | whether and the extent to which our technology and processes infringe, misappropriate or otherwise violate intellectual property of the licensor or collaboration partner that is not subject to the agreement; |

| • | the sublicensing of patents and other rights under any current or future collaboration relationships; |

| • | our diligence obligations under the agreement and what activities satisfy those diligence obligations; |

| • | our rights to transfer or assign the agreement; |

| • | the inventorship and ownership of inventions and know-how resulting from the joint creation or use of intellectual property by our licensors and us and our collaboration partners; and |

| • | the priority of invention of patented technology. |

In addition, third-party license and collaboration agreements are complex, and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, or increase what we believe to be our financial or other obligations under the relevant agreement, either of which could have a material adverse effect on our business, financial condition, results of operations, and prospects. Moreover, if disputes over intellectual property that we have licensed prevent or impair our ability to maintain our current licensing arrangements on commercially acceptable terms, we may be unable to successfully develop and commercialize the affected product candidate, which could have a material adverse effect on our business, financial conditions, results of operations, and prospects. Obligations, including contractual relationships with and statutory requirements regarding employees and others may not adequately prevent disclosure of our trade secrets and protect other proprietary information. We consider our trade secrets and proprietary confidential and unpatented know-how to be important to our business. We rely on trade secrets and confidential know-how to protect our proprietary technology, especially where patent protection is believed to be of limited value. However, trade secrets and know-how are difficult to maintain as confidential and we may, at times, have to share our trade secrets and confidential know-how with third parties with whom we collaborate for development, manufacturing or commercialization (e.g. via joint research and development programs), or withregulatory agencies with whom we interact during development and to secure approval of our current or future product candidates. To protect this type of information against disclosure or mis